Department of Medicine

Eden Biltibo is Multiple Myeloma Research Foundation scholar recipient

Vanderbilt’s Eden Biltibo, MD, MS, is one of the first recipients of the Multiple Myeloma Research Foundation’s Scholars Program, an initiative launched in 2022.

New study uses genetic data to support use of thiazide diuretics for kidney stone prevention

A Vanderbilt University Medical Center genetic association study of more than 1 million adults supports the use of the common blood thinner medication thiazide diuretics for kidney stone prevention.

doctors wearing scrubs with red aids awareness ribbons pinned to shirts

Report offers a way to overcome the severe lack of HIV providers

In a new report, members of the Southeast AIDS Education and Training Center, which is coordinated by Vanderbilt University Medical Center, offers an innovative approach to increasing the HIV workforce: train all manner of health professionals to care for people with HIV.

Study links gene network and pancreatic beta cell defects to Type 2 diabetes

A comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes.

Daniel Muñoz, MD, MPA

Daniel Muñoz and Francis Miller named interim directors of the Division of Cardiovascular Medicine

Daniel Muñoz, MD, MPA, associate professor of Medicine, and Francis Miller, MD, professor of Medicine, have been named interim directors of the Division of Cardiovascular Medicine at Vanderbilt University Medical Center.

VUMC scientists discover key step to kidney fibrosis

Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure.

1 4 5 6 7 8 102